HOME > ARCHIVE
ARCHIVE
- Korosho Study Group Issues GL on Terminal Care
April 30, 2007
- Generic Substitution Rate Remains "very Low" Despite New Prescription Form: Chuikyo
April 30, 2007
- Doctors' Average Monthly Salaries Up to \761,000
April 30, 2007
- Information on Incidence of ADRs Is Not Intellectual Property: PMDA's Mr Kishida
April 30, 2007
- Status of 5 Major Diseases in 2015 Surveyed: JHSF
April 30, 2007
- 29 New Drugs Approved
April 30, 2007
- Plavix to Drive Sales of sanofi-aventis in 2007: Mr Fauchet
April 30, 2007
- Expert Group Starts Discussing Compassionate Use of Unapproved Drugs
April 30, 2007
- Shionogi to Hire More MRs to Promote Crestor, Irbesartan
April 23, 2007
- Medical Spending Should Be Increased: JMA President
April 23, 2007
- Asahi Kasei to Focus on 3 Fields
April 23, 2007
- Strict Control of cholesterol Required in Hyperlipidemia Patients with Diabetes
April 23, 2007
- Explosion at Shin-Etsu Chemical Affects Supply of Cellulose Derivatives
April 23, 2007
- Early Treatment of Hepatitis C Needed to Prevent Liver Cancer
April 23, 2007
- System That Reduces Number of Quick Deliveries Needed: Mr Choufuku of Mediceo Paltac
April 23, 2007
- TOPICS/NOXAFIL Recommended for Antifungal Prophylaxis: Schering-Plough
April 23, 2007
- Korosho to Hear Wholesalers, Hospitals, Pharmacies Again Over Agreements on Prices
April 23, 2007
- Bayer Yakuhin to Integrate Nihon Schering in July: Dr Portoff
April 23, 2007
- BUSINESS NEWS IN BRIEF
April 23, 2007
- 27th General Assembly of the Japan Medical Congress
April 23, 2007
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
